It was later clarified in the 2015 annual report that half-year revenue of $2.5 million will be sufficient to satisfy milestone A; $3.75 million for milestone B; and $5 million for milestone C.That statement is misleading !!
The Notice of General Meeting/Proxy Form (19/11/2014) https://www.asx.com.au/asxpdf/20141119/pdf/42ttr3xjzcnwfk.pdf had the following:
- Forums
- ASX - By Stock
- SP1
- AFR article
AFR article, page-14
-
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SP1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online